Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fc epsilon RI (FcεRI) is the high-affinity receptor for immunoglobulin E (IgE), playing a central role in allergic responses and immune defense against parasites. It is a multimeric receptor complex expressed mainly on mast cells and basophils, but also on other immune cells. Crosslinking of IgE bound to FcεRI by allergens triggers degranulation and release of inflammatory mediators, leading to allergic symptoms. It is a critical target for therapies aimed at treating allergies or modulating immune responses involving mast cell activation.
Blocking IgE binding or downstream signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fc epsilon RI Receptor (FcεRI).